Company: HRTX
Filing Date: 2025-02-27
Form Type: 8-K
Source: 0000950170-25-028372
Chunk: 0

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-02-27
Form: 8-K
Item: Item 2.02
Chunk 0
---
Item 2.02 Results of Operations and Financial Condition.

On February 27, 2025, Heron Therapeutics, Inc. (“ Company”) issued a press release announcing its financial results for the three and twelve months ended December 31, 2024 (“ Earnings Press Release”). A copy of the Earnings Press Release is furnished as Exhibit 99.1.

This Item 2.02 and the Earnings Press Release attached hereto as Exhibit 99.1, insofar as they disclose information regarding the Company’s results of operations or financial condition for the three and twelve months ended December 31, 2024, are being furnished to the Securities and Exchange Commission.

Item 9.01 Financial Statements and Exhibits.